Medical treatment for uterine myomas

Taiwanese Journal of Obstetrics & Gynecology
Ming-Hui ChengPeng-Hui Wang

Abstract

Uterine myomas are the most common benign tumors in the female reproductive tract. Most women with myomas are asymptomatic. Therefore, expectant observation and follow-up are often recommended for these myoma patients. However, myomas may cause menstrual symptoms, pelvic pain, pressure complaints, subfertility or pregnancy-related complications, with resultant requests for a definitive treatment. The management of myomas has become multidisciplinary in the past 20 years. Basically, the choice of treatment depends on the patient's age, the reason for treatment, the issue of fertility preservation, and the patient's preference. The treatment spectrum includes an expectant management, medical therapy, surgical intervention, uterine artery embolization or ablative techniques. Medical therapy is an option for women with symptomatic myomas who prefer non-surgical treatment, consider fertility preservation, or expect a less aggressive operation after shrinkage of the uterine volume. This review will summarize the recent well-documented drugs for the management of uterine myomas.

References

Jan 1, 1986·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·S G SilverbergT Luukkainen
Sep 1, 1995·Obstetrics and Gynecology·J L RutgersJ Heiner
Sep 1, 1994·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·H A Van Leusden
Sep 1, 1996·European Journal of Obstetrics, Gynecology, and Reproductive Biology·T HigashijimaM Yakushiji
Oct 23, 1998·The Journal of the American Association of Gynecologic Laparoscopists·F ZulloE Zupi
May 10, 2001·Clinical Obstetrics and Gynecology·S M Schwartz
Dec 12, 2003·Fertility and Sterility·Sheri A LippmanBrenda Eskenazi
Oct 30, 2004·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·T FuruiS Shiraki
Apr 22, 2005·BJOG : an International Journal of Obstetrics and Gynaecology·P A FliermanS de Blok
Apr 23, 2005·American Journal of Obstetrics and Gynecology·Eva ChalasCarolyn D Runowicz
Jan 2, 2007·Taiwanese Journal of Obstetrics & Gynecology·Chun-Chieh ChiaChing-Cheng Zheng
Apr 17, 2007·Gynecologic Oncology·Robert L GiuntoliBobbie S Gostout
Jul 20, 2007·Taiwanese Journal of Obstetrics & Gynecology·Peng-Hui WangKuan-Chong Chao
Sep 11, 2007·Gynecologic Oncology·Wen-Ling LeePeng-Hui Wang
Nov 21, 2007·Maturitas·Peng-Hui WangWen-Ling Lee
Jan 10, 2008·Taiwanese Journal of Obstetrics & Gynecology·Ming-Huei ChengPeng-Hui Wang

❮ Previous
Next ❯

Citations

Nov 3, 2015·Taiwanese Journal of Obstetrics & Gynecology·Yi-Jen ChenUNKNOWN Taiwan Association of Gynecology Systematic Review Group
Oct 3, 2009·Taiwanese Journal of Obstetrics & Gynecology·Peng-Hui WangWei-Min Liu
Apr 10, 2012·Taiwanese Journal of Obstetrics & Gynecology·Kuan Chiao LeePeng-Hui Wang
Apr 10, 2012·Taiwanese Journal of Obstetrics & Gynecology·Huann-Cheng HorngPeng-Hui Wang
Apr 29, 2014·Taiwanese Journal of Obstetrics & Gynecology·Kuan-Hao TsuiChih-Ping Chen
Dec 17, 2014·Taiwanese Journal of Obstetrics & Gynecology·Kuan-Hao TsuiPeng-Hui Wang
Jul 4, 2009·Taiwanese Journal of Obstetrics & Gynecology·Peng-Hui WangHsiang-Tai Chao
May 15, 2010·Taiwanese Journal of Obstetrics & Gynecology·Peng-Hui WangKuan-Chong Chao
Jun 17, 2009·The Journal of Obstetrics and Gynaecology Research·Peng-Hui WangKuan-Chong Chao
Apr 2, 2009·The Journal of Obstetrics and Gynaecology Research·Le-Ming WangWei-Min Liu
Jan 29, 2011·The Journal of Obstetrics and Gynaecology Research·Kuo-Chang WenPeng-Hui Wang
Jun 12, 2012·Expert Opinion on Drug Metabolism & Toxicology·Gian Benedetto MelisAnna Maria Paoletti
Oct 24, 2012·Journal of the Chinese Medical Association : JCMA·Wen-Hsiang SuPeng-Hui Wang
Apr 29, 2014·Taiwanese Journal of Obstetrics & Gynecology·Huann-Cheng HorngMing-Shyen Yen
Aug 17, 2010·Taiwanese Journal of Obstetrics & Gynecology·Kuan Chiao LeePeng-Hui Wang
Jul 22, 2017·Journal of the Chinese Medical Association : JCMA·Huann-Cheng HorngPeng-Hui Wang
May 14, 2010·Systems Biology in Reproductive Medicine·Yong JiangJean Y J Wang
Dec 4, 2014·Bulletin of Mathematical Biology·C Y Chen, J P Ward

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved